GlassScriptPhysician profile
Amanda Abrams Gunn
NPI 1528488442
$20,003.30
in general payments reported to CMS, 2019-2025
28 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $649 · 2022: $15K · 2023: $2,528 · 2024: $671 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Long Term Medical Supply Or Device Loan: $2,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,134.46 |
| Long Term Medical Supply Or Device Loan | $2,083.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17,083.34 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Genzyme Corporation | $544.52 | 2023-2025 | |
| Glaxosmithkline, LLC. | $452.28 | 2021-2025 | Nucala |
| Optinose US, INC. | $414.23 | 2023-2025 | |
| Organogenesis INC. | $354.24 | 2022-2024 | Puraply |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.31 | 2021-2022 | |
| Abbott Laboratories | $128.80 | 2021-2025 | Prodigy, Proclaim |
| Aerin Medical INC. | $104.84 | 2024-2025 | |
| Pfizer INC. | $78.39 | 2021 | |
| Boston Scientific Corporation | $68.04 | 2021-2025 | General - Pain Management |
| Regeneron Healthcare Solutions, INC. | $62.88 | 2024 | Dupixent |
| Hill Dermaceuticals, INC. | $59.73 | 2025 | Tolak |
| Novo Nordisk INC | $51.92 | 2021 | |
| Baxter Healthcare | $47.99 | 2024 | Perclot |
| Janssen Pharmaceuticals, INC | $45.38 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $43.86 | 2021 | |
| Urgo Medical North America, LLC | $30.97 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Merck Sharp & Dohme LLC | $30.75 | 2021 | |
| Smith+Nephew, INC. | $30.40 | 2025 | Collagenase Santyl |
| Lucid Diagnostics INC. | $29.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.49 | 2021 | |
| Solventum Corporation | $19.06 | 2025 | Activ.A.C. |
| Phadia US INC. | $17.73 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.86 | 2021 | |
| Lilly USA, LLC | $16.42 | 2021 | |
| Stryker Corporation | $14.72 | 2025 | Audion Et Dilation System |
| Vistapharm, INC. | $14.68 | 2021 | |
| Axonics, INC. | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Gunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.